SG50452A1 - Prevention of glucocorticoid-induced skin atrophy - Google Patents

Prevention of glucocorticoid-induced skin atrophy

Info

Publication number
SG50452A1
SG50452A1 SG1996001764A SG1996001764A SG50452A1 SG 50452 A1 SG50452 A1 SG 50452A1 SG 1996001764 A SG1996001764 A SG 1996001764A SG 1996001764 A SG1996001764 A SG 1996001764A SG 50452 A1 SG50452 A1 SG 50452A1
Authority
SG
Singapore
Prior art keywords
glucocorticoid
prevention
induced skin
skin atrophy
atrophy
Prior art date
Application number
SG1996001764A
Other languages
English (en)
Inventor
Albert M Kligman
James A Mezick
Robert J Capetola
Original Assignee
Ortho Pharamaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharamaceutical Corp filed Critical Ortho Pharamaceutical Corp
Publication of SG50452A1 publication Critical patent/SG50452A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG1996001764A 1986-11-03 1987-11-02 Prevention of glucocorticoid-induced skin atrophy SG50452A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/925,935 US4889847A (en) 1986-11-03 1986-11-03 Prevention of glucocorticoid-induced skin atrophy

Publications (1)

Publication Number Publication Date
SG50452A1 true SG50452A1 (en) 1998-07-20

Family

ID=25452450

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996001764A SG50452A1 (en) 1986-11-03 1987-11-02 Prevention of glucocorticoid-induced skin atrophy

Country Status (7)

Country Link
US (1) US4889847A (da)
EP (1) EP0266992A3 (da)
JP (1) JPS63152313A (da)
AU (1) AU591587B2 (da)
DK (1) DK574287A (da)
SG (1) SG50452A1 (da)
ZA (1) ZA878214B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019569A (en) * 1986-11-03 1991-05-28 Ortho Pharmaceutical Corporation Reversal of glucocorticoid-induced skin atrophy
WO1988007857A1 (en) * 1987-04-06 1988-10-20 Daltex Medical Sciences, Inc. Treatment of aged skin with oral 13-cis-retinoic acid
ZA885192B (en) * 1987-08-19 1989-04-26 Hoffmann La Roche Pharmaceutical preparations
US5134163A (en) * 1989-09-01 1992-07-28 Kligman Albert M Methods of preventing and reducing the size of striae distensae lesions
CA2044162A1 (fr) * 1989-10-13 1991-04-14 Jacques Borg Derives des alcools gras a longue chaine, leurs applications, notamment en tant que molecules cytotrophes et cytoprotectrices, et compositions pharmaceutiques les contenant
CA2035594A1 (en) * 1990-02-12 1991-08-13 Ronald J. Shannon Use of retinoids to minimize skin damage
US5070108A (en) * 1990-10-12 1991-12-03 Trustees Of The University Of Pennsylvania Methods of treating osteoporosis, increasing bone mineral content and preventing the occurrence of compression fractures in a mammal
US5254343A (en) * 1991-03-19 1993-10-19 Bristol-Myers Squibb Company Reduction of cutaneous atrophy
EP0625045A4 (en) * 1992-02-07 1995-01-18 Albert M Kligman METHOD FOR TREATING FLAMMABLE DERMATOS.
US6093706A (en) * 1992-03-04 2000-07-25 Bioresponse, L.L.C. Combined dehydroepiandrosterone and retinoid therapy for epithelial disorders
US7655699B1 (en) 1992-04-22 2010-02-02 Eisai Inc. Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
US6344448B1 (en) 1992-09-11 2002-02-05 Stb Family Limited Partnership Composition for the treatment of hair loss
CA2129773C (en) * 1993-09-02 2007-05-01 Michael Klaus Aromatic carboxylic acid derivatives
US5401811A (en) * 1994-05-03 1995-03-28 Eastman Chemical Company Continuous process for the oxidation of polyethylene
US7115728B1 (en) 1995-01-30 2006-10-03 Ligand Pharmaceutical Incorporated Human peroxisome proliferator activated receptor γ
US6380255B1 (en) 1995-06-07 2002-04-30 Karo Bio Ab Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds
FR2735371B1 (fr) * 1995-06-19 1997-07-18 Cird Galderma Procede pour identifier des composes antagonistes des recepteurs rars
EP0986379A4 (en) * 1997-02-21 2002-11-13 Bristol Myers Squibb Co USE OF SUBSTITUTED (5,6) DIHYDRONAPHTHALEN COMPOUNDS WITH RETINOID-LIKE ACTIVITY FOR PREVENTING OR REDUCING ISCHEMIC DAMAGE
USH2043H1 (en) 1997-05-23 2002-08-06 The Procter & Gamble Company Skin care compositions
WO1999005161A1 (en) 1997-07-25 1999-02-04 Ligand Pharmaceuticals Incorporated HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA (PPARη) GENE REGULATORY SEQUENCES AND USES THEREFOR
CA2334545A1 (en) * 1998-06-12 1999-12-16 Ligand Pharmaceuticals Incorporated Treatment of anti-estrogen resistant breast cancer using rxr modulators
HUE041585T2 (hu) 2004-09-28 2019-05-28 Avivagen Inc Kompozíciók és eljárások súlygyarapodás és táplálék konverzió elõsegítésére
PL2214656T3 (pl) * 2007-10-26 2019-06-28 Avivagen Inc. Kompozycje i sposoby wzmacniania odpowiedzi immunologicznej
CA2771204C (en) 2009-04-30 2017-09-19 Chemaphor Inc. Methods and compositions for improving the health of animals
WO2014151221A1 (en) 2013-03-15 2014-09-25 The Procter & Gamble Company Renewable thermoplastic starch - polyolefin compositions comprising compatibilizer and flexible thin films made therefrom
WO2015066588A1 (en) 2013-11-04 2015-05-07 The Procter & Gamble Company Thermoplastic polymer compositions having co-continuous plate-like morphology
US11045441B2 (en) 2015-10-13 2021-06-29 Wisconsin Alumni Research Foundation Use of retinoic acid and analogs thereof to treat central neural apneas

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3729568A (en) * 1969-09-23 1973-04-24 Johnson & Johnson Acne treatment
IN142640B (da) * 1975-01-17 1977-08-06 Johnson & Johnson
GB1487543A (en) * 1975-05-11 1977-10-05 Dso Pharmachim Dermatological composition
US4126643A (en) * 1977-11-14 1978-11-21 Shell Oil Company Butadiene (1,3) conversion
US4487782A (en) * 1982-03-26 1984-12-11 Ortho Pharmaceutical Corporation Topical treatment of non-inflammatory acne
EP0196121A1 (en) * 1985-02-22 1986-10-01 Pera Dr. Visnjic Process for obtaining the preparation for the treatment of the disease psoriasis; drug for the treatment of psoriasis and its application
SE462139B (sv) * 1986-02-04 1990-05-14 Sven Moberg Farmaceutisk komposition, innehaallande propylenglykol och karbamid, foer behandling av bl.a. nagelsvamp och seborroiskt eksem

Also Published As

Publication number Publication date
AU8061387A (en) 1988-05-05
EP0266992A2 (en) 1988-05-11
EP0266992A3 (en) 1990-05-16
JPS63152313A (ja) 1988-06-24
US4889847A (en) 1989-12-26
DK574287A (da) 1988-05-04
AU591587B2 (en) 1989-12-07
ZA878214B (en) 1989-06-28
DK574287D0 (da) 1987-11-02

Similar Documents

Publication Publication Date Title
AU591587B2 (en) Prevention of glucocorticoid-induced skin atrophy
GB8720521D0 (en) Prevention of tampering
GB2223959B (en) Treatment of nitrophenolic by-products
IL83663A0 (en) Preparation of 3-pyrrolidinols
CS439687A2 (en) Emulsion of /e/-0-2-isopropoxycarbonyl-1-methylvinyl-0-methylethylphosphoramidothionate
IL83798A (en) 13-deoxy-23-oxo(keto)and 23-imino derivatives of 13-deoxy c-076-aglycone compounds and their pesticidal use
GB2217729B (en) Obtenation of scualane
GB8727401D0 (en) Preparation of trifluoromethylbenzonitrile
GB8718630D0 (en) Preventing fogging of surfaces
GB8802421D0 (en) Set of parts
IL82218A (en) Preparation of 1-aryl-5-amino-pyrazoles
GB2191329B (en) Decontamination of surfaces
IE872956L (en) Prevention of glucocorticoid-induced skin atrophy
IL84778A0 (en) Preparation of mercaptobenzoates
IL82217A0 (en) Preparation of 1-aryl-5-amino-pyrazoles
GB8601724D0 (en) Application of tetracyano-quinodimethanes
GB2196961B (en) Preparation of polyfluoroenolates
GB8602313D0 (en) Reduction of photo-yellowing
EP0243643A3 (en) Isolation of persons
GB2197347B (en) Heat-treatment of small parts
GB8704561D0 (en) Application of tetrathiafulvalenes
IL82018A0 (en) Preparation of 4-nitrophenetol
GB8628710D0 (en) Piegon of piece
IE893961L (en) Reduction of piperidine-diones
IE862794L (en) Derivatives of 3-imino-pyridazine